|
|
INTERESTING IMAGES |
|
|
|
Year : 2016 | Volume
: 31
| Issue : 2 | Page : 152-153 |
|
|
Calcified peritoneal metastasis identified on 18F-fluoride positron emission tomography/computed tomography: Importance of extraosseous uptake of F-18 fluoride
Priyanka Verma, Piyush Chandra, Archi Agrawal, Nilendu Purandare, Sneha Shah, Venkatesh Rangarajan
Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India
Date of Web Publication | 9-Mar-2016 |
Correspondence Address: Venkatesh Rangarajan Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Parel, Mumbai - 400 012, Maharashtra India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0972-3919.178333
Abstract | | |
F-18 NaF positron emission tomography/computed tomography (PET/CT) is used for the evaluation of malignant and nonmalignant osseous disease. Extraosseous uptake of 18 fluoride-NaF has been observed in the arterial vasculature, gastrointestinal tract, and genitourinary tract. We describe a case of a woman with carcinoma of unknown primary in whom F-18 NaF PET/CT showed tracer uptake in the calcified peritoneal metastasis. Extraosseous findings on F-18 NaF PET/CT, though rare, may be visualized and may result in important management changes. Keywords: 18F-fluoride positron emission tomography/computed tomography, bone scintigraphy, calcified soft tissue metastasis, extraosseous finding
How to cite this article: Verma P, Chandra P, Agrawal A, Purandare N, Shah S, Rangarajan V. Calcified peritoneal metastasis identified on 18F-fluoride positron emission tomography/computed tomography: Importance of extraosseous uptake of F-18 fluoride. Indian J Nucl Med 2016;31:152-3 |
How to cite this URL: Verma P, Chandra P, Agrawal A, Purandare N, Shah S, Rangarajan V. Calcified peritoneal metastasis identified on 18F-fluoride positron emission tomography/computed tomography: Importance of extraosseous uptake of F-18 fluoride. Indian J Nucl Med [serial online] 2016 [cited 2022 Aug 20];31:152-3. Available from: https://www.ijnm.in/text.asp?2016/31/2/152/178333 |
F-18 NaF positron emission tomography/computed tomography (PET/CT) is used routinely for bone imaging for the detection of malignant and nonmalignant osseous disease. [1],[2] Extraosseous uptake of 18F-NaF (18 fluoride NaF) has been observed in structures such as the arterial vasculature, gastrointestinal tract, and genitourinary tract. [3],[4],[5],[6] As a bone-seeking radiopharmaceutical, 18F-NaF can localize in extraosseous calcifying lesions. Lesions containing dystrophic or microscopic calcification or calcified visceral metastases can show focal uptake of 18F-NaF. [7],[8],[9],[10] Tc-99m methylene diphosphonate uptake has been reported in ovarian carcinoma and its soft tissue metastases. [11] In literature, there is one case report of F-18 fluoride uptake in calcified extraosseous metastases from ovarian papillary serous adenocarcinoma. [12] We describe a case of a 73-year-old woman with carcinoma of unknown primary in whom F-18 NAF PET/CT showed tracer uptake in the calcified peritoneal metastasis. She presented with abdominal distension, and ascitic fluid cytology was positive for malignant cells, suggestive of metastatic adenocarcinoma. She underwent F-18F bone scan for evaluation of skeletal metastases. Whole body F-18F PET/CT maximum intensity projection (MIP) [Figure 1] showed focal increased tracer uptake in the right iliac fossa. Axial PET/CT fused [Figure 2] showed increased tracer uptake corresponding to calcified soft tissue peritoneal metastasis. No evidence of skeletal metastases was seen. [Figure 3] shows the coronal and sagittal images of the same patient. Contrast-enhanced CT scan [Figure 4] was done, which demonstrated the presence of calcified peritoneal metastasis. However, the primary site could not be identified. The patient was given a diagnosis of peritoneal metastases with an unknown primary and was referred for chemotherapy. Extraosseous findings on F-18 NaF PET/CT, like the one described here, though rare, may be visualized and may result in important management changes, if it is a metastatic site as in our case. However, confirmation with histology or other imaging modality should be made. | Figure 1: Whole body 18-F fluoride positron emission tomography/computed tomography maximum intensity projection image shows focal increased tracer uptake tracer uptake in the right iliac fossa. No evidence of skeletal metastases was seen
Click here to view |
 | Figure 2: Axial positron emission tomography/computed tomography fused image shows increased tracer uptake corresponding to calcified soft tissue peritoneal metastasis
Click here to view |
 | Figure 4: The axial and coronal contrast-enhanced computed tomography images showing the calcified soft tissue peritoneal metastasis
Click here to view |
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | |  |
1. | Bastawrous S, Bhargava P, Behnia F, Djang DS, Haseley DR. Newer PET application with an old tracer: Role of 18F-NaF skeletal PET/CT in oncologic practice. Radiographics 2014;34:1295-316. |
2. | Segall G, Delbeke D, Stabin MG, Even-Sapir E, Fair J, Sajdak R, et al. SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0. J Nucl Med 2010;51:1813-20. |
3. | Derlin T, Tóth Z, Papp L, Wisotzki C, Apostolova I, Habermann CR, et al. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: A dual-tracer PET/CT study. J Nucl Med 2011;52:1020-7. |
4. | Love C, Din AS, Tomas MB, Kalapparambath TP, Palestro CJ. Radionuclide bone imaging: An illustrative review. Radiographics 2003;23:341-58. |
5. | Chakraborty PS, Karunanithi S, Dhull VS, Kumar K, Tripathi M. Dystrophic calcification in muscles of legs in calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia syndrome: Accurate evaluation of the extent with (99m) Tc-methylene diphosphonate single photon emission computed tomography/computed tomography. Indian J Nucl Med 2015;30:360-1.  [ PUBMED] |
6. | Zuckier LS, Freeman LM. Nonosseous, nonurologic uptake on bone scintigraphy: Atlas and analysis. Semin Nucl Med 2010;40:242-56. |
7. | Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F-fluoride: Applying new technology to an old tracer. J Nucl Med 2008;49:68-78. |
8. | Kulkarni M, Agrawal A, Zade A, Purandare N, Shah S, Rangarajan V. Extraosseous accumulation of bone scan tracer (99m) Tc-methylene diphosphonate in a phlebolith. Indian J Nucl Med 2012;27:42-4.  [ PUBMED] |
9. | Kuyumcu S, Adalet I, Isik EG, Unal SN. Impact of nonosseous findings on (18) F-NaF PET/CT in a patient with ductal breast carcinoma. Nucl Med Mol Imaging 2014;48:72-4. |
10. | Swietaszczyk C, Prasad V, Baum RP. Intense 18F-fluoride accumulation in liver metastases from a neuroendocrine tumor after peptide receptor radionuclide therapy. Clin Nucl Med 2012;37:e82-3. |
11. | Beres RA, Patel N, Krasnow AZ, Isitman AT, Hellman RS, Veluvolu P, et al. Concentration of Tc-99m MDP in ovarian carcinoma and its soft tissue metastases. Clin Nucl Med 1991;16:550-2. |
12. | Agrawal K, Bhattacharya A, Harisankar CN, Abrar ML, Dhaliwal LK, Mittal BR. F-18 fluoride uptake in calcified extraosseous metastases from ovarian papillary serous adenocarcinoma. Clin Nucl Med 2012;37:e22-3. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
|